Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Dimitri Yellachich is active.

Publication


Featured researches published by Dimitri Yellachich.


Retina-the Journal of Retinal and Vitreous Diseases | 2006

Semiautomated patterned scanning laser for retinal photocoagulation.

Mark S. Blumenkranz; Dimitri Yellachich; Dan Andersen; Michael Wiltberger; David H. Mordaunt; George Marcellino; Daniel Palanker

The concept of retinal photocoagulation was introduced by Meyer-Schwickerath for the treatment of diabetic retinopathy in the 1950s and used with some success in the 1960s. The xenon arc photocoagulator utilized for this purpose was large, polychromatic, inefficient, and difficult to operate, prompting a search for a better method of treatment. Further progress was achieved when ruby,1 argon ion,2 and krypton ion3 lasers were coupled to a slit lamp with an articulating arm containing mirrors.4 A contact lens, aiming beam, and movable joystick were used to place the laser beam on the retina. These innovations allowed for creating single laser spots of variable size, power, and duration on the retina with a high degree of precision and ushered in the modern era of retinal laser photocoagulation in the 1970s. The techniques enabled by these devices, termed focal photocoagulation, grid photocoagulation, and panretinal photocoagulation, were refined and shown to be effective in the treatment of proliferative diabetic retinopathy and advanced forms of nonproliferative diabetic retinopathy associated with macular edema in large, prospective, multicenter, randomized trials—the DRS and ETDRS.5,6 These trials validated the efficacy and institutionalized the indications and parameters for treatment that have remained the gold standard since that time. Patients with high risk proliferative diabetic retinopathy who undergo panretinal photocoagulation typically receive between 1,200 and 1,500 laser spots in two to four sessions of 10 minutes to 20 minutes each over the course of 2 weeks to 4 weeks. Because the spots are delivered individually, treatments are time consuming and tedious for the patient and physician alike and can be painful, especially in the retinal periphery. Focal photocoagulation and grid photocoagulation for macular edema are less painful and time consuming, because the spots are applied more posteriorly and are fewer in number, but still are tedious and require a considerable degree of patient cooperation and physician skill to achieve a successful outcome and avoid complications. Until now, little has changed in the general design of the devices used for retinal photocoagulation aside from the substitution of fiber-optic cables for articulating arms and the use of air-cooled solid state lasers rather than water-cooled gas tubes. These innovations have had limited or no impact from the standpoint of the patient or physician on the technique of treatments and clinical outcomes. We reasoned that greater precision and safety in retinal photocoagulation might be achieved by delivering a multiplicity of spots in a pattern created by a scanner rather than as a series of individually placed lesions. We also wondered whether the pattern application time and patient discomfort could be further reduced by using shorter pulses than the conventional 100 milliseconds to 200 milliseconds recommended in the DRS and ETDRS.5,6 Prior efforts toward improvement in retinal photocoagulation systems were principally directed toward (1) fully automated systems with retinal stabilization based on eye tracking7–10 and (2) determination of the optimal dose in each spot using the tissue reflectance– based feedback systems.11 Automated systems required acquisition of an image of the retina before the treatment, planning and aligning all treatment locations with reference to the retinal image, and treating all of these locations automatically. Complex retinal tracking systems were also required in these approaches to ensure alignment between planned treatment locations defined on the acquired image and actual sites on the retina.7–10 The complexity of these fully automated systems hampered the introduction of


Biomedical optics | 2005

Optical monitoring of thermal effects in RPE during heating

Georg Schuele; Philip Huie; Dimitri Yellachich; F.E. Molnar; Caitlin O’Conell-Rodwell; Edward Vitkin; Lev T. Perelman; Daniel Palanker

Fast and non-invasive detection of cellular stress is useful for fundamental research and practical applications in medicine and biology. Using Light Scattering Spectroscopy we extract information about changes in refractive index and size of the cellular organelles. Particle sizes down to 50nm in diameter can be detected using light within the spectral range of 450-850 nm. We monitor the heat-induced sub-cellular structural changes in human RPE cells and, for comparison, in transfected NIH-3T3 cells which express luciferase linked to the heat shock protein (HSP). Using inverse light scattering fitting algorithm, we reconstruct the size distribution of the sub-micron organelles from the light scattering spectrum. The most significant (up to 70%) and rapid (20sec) temperature-related changes can be linked to an increase of refractive index of the 160nm sized mitochondria. The start of this effect coincides with the onset of HSP expression. This technique provides an insight into metabolic processes within organelles larger than 50nm without exogenous staining and opens doors for non-invasive real-time assessment of cellular stress, which can be used for monitoring of retinal laser treatments like transpupillary thermo therapy or PDT.


Biomedical optics | 2006

Noninvasive Dosimetry and Monitoring of TTT Using Spectral Imaging

Georg Schuele; F.E. Molnar; Dimitri Yellachich; Edward Vitkin; Lev T. Perelman; Daniel Palanker

Transpupillary thermo therapy (TTT) is a slow (60 seconds) photothermal treatment of the fundus with a near-infrared (780-810nm) laser irradiating a large spot (0.5- 1. mm) on the retina. Due to high variability in ocular tissue properties and the lack of immediately observable outcome of the therapy, a real-time dosimetry is highly desirable. We found that fundus spectroscopy and spectrally-resolved imaging allow for non-invasive real-time monitoring and dosimetry of TTT. A 795nm laser was applied in rabbit eyes for 60 seconds using a 0.86mm retinal spot diameter. The fundus was illuminated with a broadband polarized light, and its reflectance spectra were measured in parallel and cross-polarizations. The fundus was also imaged in selected spectral domains. At irradiances that do not create ophthalmoscopically visible lesions the fundus reflectance increases at the wavelengths corresponding to absorption of the oxygenated blood indicating the reduced concentration of blood in the choroid. Vasoconstrictive response of the choroidal and retinal vasculature during TTT was also directly observed using spectrally-resolved imaging. At irradiances that produce ophthalmoscopically visible lesions a rapid reduction of the fundus reflectance was observed within the first 5-10 seconds of the exposure even when the visible lesions developed only by the end of the 60 second exposure. No visible lesions were produced where the laser was terminated after detection of the reduced scattering but prior to appearance of the enhanced scattering.


Archive | 2003

Patterned laser treatment of the retina

Mark S. Blumenkranz; Daniel Palanker; Dimitri Yellachich


Archive | 2010

Patterned Laser Treatment

Mark S. Blumenkranz; Daniel Palanker; Dimitri Yellachich


Archive | 2005

Artificial biocompatible material as a support for cells in a retinal implant

Theodore Leng; Dimitri Yellachich; Philip Huie; Jaan Noolandi; Harvey A. Fishman


Investigative Ophthalmology & Visual Science | 2005

Synthetic Bruch's Membrane Substitutes: Comparisons After Subretinal Transplantation With Cultured Iris Pigment Epithelium

F.E. Molnar; L. Lombardi; N. Berker; E. Yeh; Dimitri Yellachich; Theodore Leng; Roopa Dalal; Michael F. Marmor; Harvey A. Fishman; Mark S. Blumenkranz


Investigative Ophthalmology & Visual Science | 2004

Autologous iris pigment epithelium cultured on cellulose acetate membrane transplanted into the subretinal space of rabbits

Dimitri Yellachich; Theodore Leng; P. Huie; J. Noolandi; Mark S. Blumenkranz; Michael F. Marmor; Harvey A. Fishman


Archive | 2012

System for the treatment of the patient's retina of the eye with a laser

Mark S. Blumenkranz; Daniel Palanker; Dimitri Yellachich


Investigative Ophthalmology & Visual Science | 2006

Semi–Automated Pan–Retinal Photocoagulation in Patients With Diabetic Retinopathy

Dimitri Yellachich; Daniel Palanker; D.E. Andersen; M.W. Wiltberger; D. Mordaunt; G.R. Marcellino; V. Morales–Canton; H. Quiroz–Mercado; Mark S. Blumenkranz

Collaboration


Dive into the Dimitri Yellachich's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge